The global laser capture microdissection market accounted for USD 163.1 Million in 2023 and is expected to reach USD 495.5 Million by 2034 with a CAGR of 10.63% during the forecast period 2024-2034. The market will grow as a result of developments in molecular biology and biotechnology, personalized medicine becoming more and more important, rising rates of cancer and other diseases, technological advancements in LCM systems, and partnerships and collaborations in the research community.
The demand for cutting-edge research instruments to examine disease mechanisms, biomarkers, and possible treatment targets has increased due to the rising incidence of cancer and other complicated diseases. Through the isolation of uncommon or particular cell types within tumor tissues, LCM enables thorough molecular profiling as well as a more profound understanding of the course of the disease and the effectiveness of treatment. For instance, Leica Microsystems announced the release of its new LMD7 laser microdissection platform in February 2022.
By product, the instruments segment accounted for the highest revenue-grossing segment in the global laser capture microdissection market in 2023 owing to the increased adoption of advanced and user-friendly LCM systems with enhanced precision and compatibility with downstream molecular analysis techniques. For instance, Thermo Fisher Scientific stated in January 2022 that it was expanding its portfolio by acquiring Wasatch Photonics, a producer of high-performance Raman spectroscopy products. Additionally, the consumables segment is predicted to grow at the fastest CAGR during the forecast period owing to the growing demand for high-quality consumables such as reagents, kits, and disposable caps for sample collection, which are essential for maximizing the efficiency and accuracy of laser capture microdissection procedures.
By system type, the ultraviolet (UV) LCM segment accounted for the highest revenue-grossing segment in the global laser capture microdissection market in 2023 owing to the increasing adoption of UV LCM technology due to its superior precision, versatility, and compatibility with downstream molecular analysis applications, such as genomics and proteomics. For instance, Danaher Corporation stated in January 2022 that it had successfully acquired Aldevron, a supplier of premium plasmid DNA, mRNA, and proteins for biopharmaceutical applications. Additionally, the infrared (IR) LCM segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising demand for non-destructive tissue microdissection, improved sample preservation, and enhanced compatibility with a wider range of tissue types and downstream molecular analysis techniques.
By application, the research and development (R&D) segment accounted for the highest revenue-grossing segment in the global laser capture microdissection market in 2023 owing to the growing investments in research and development activities aimed at expanding the applications of laser capture microdissection across various fields, including oncology, neuroscience, and regenerative medicine. For instance, in January 2022, Danaher Corporation announced that it had acquired Aldevron, a provider of premium proteins, mRNA, and plasmid DNA for biopharmaceutical applications, successfully. Additionally, the diagnostics segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing demand for precise and reliable diagnostic tools for disease detection and personalized medicine, driving the adoption of laser capture microdissection technology in clinical diagnostics.
By end-user, the academic and government research institutes segment accounted for the highest revenue-grossing segment in the global laser capture microdissection market in 2023 owing to the increasing funding for life sciences research and collaborations between academic institutions and government agencies, driving the adoption of laser capture microdissection technology for various research applications. For instance, Crown Bioscience International (US), a JSR Life Sciences Company, purchased a 100% interest in Indivumed Services GmbH& Co. KG (Germany) in March 2023 in order to enhance drug discovery and develop solutions to satisfy client demands by integrating a range of complementary service platforms with Crown Bioscience's drug discovery and development offerings. Additionally, the pharmaceutical and biotechnology company segment is predicted to grow at the fastest CAGR during the forecast period owing to the growing focus on drug discovery, personalized medicine, and biomarker research, leading to increased investment in advanced technologies like laser capture microdissection for target identification and validation.
North American region is anticipated to have the highest revenue share during the forecast period owing to the region's well-established healthcare infrastructure, robust research and development activities, high adoption of advanced technologies, and presence of key market players driving innovation and market growth in laser capture microdissection. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the region's increasing investments in healthcare infrastructure, rising prevalence of chronic diseases, growing research and development activities, and expanding adoption of advanced biotechnological tools, including laser capture microdissection, across academic, clinical, and industrial sectors. For instance, Maastricht University published a research article in 2022 titled "Single-Cell RNA Sequencing and Laser Capture Microdissection-Based mRNA Expression Microarrays in Atherosclerosis Research."
This extensive research report concentrates on the size and projections of the global and regional markets from 2023 to 2034.
The demand for cutting-edge research instruments to examine disease mechanisms, biomarkers, and possible treatment targets has increased due to the rising incidence of cancer and other complicated diseases. Through the isolation of uncommon or particular cell types within tumor tissues, LCM enables thorough molecular profiling as well as a more profound understanding of the course of the disease and the effectiveness of treatment. For instance, Leica Microsystems announced the release of its new LMD7 laser microdissection platform in February 2022.
By product, the instruments segment accounted for the highest revenue-grossing segment in the global laser capture microdissection market in 2023 owing to the increased adoption of advanced and user-friendly LCM systems with enhanced precision and compatibility with downstream molecular analysis techniques. For instance, Thermo Fisher Scientific stated in January 2022 that it was expanding its portfolio by acquiring Wasatch Photonics, a producer of high-performance Raman spectroscopy products. Additionally, the consumables segment is predicted to grow at the fastest CAGR during the forecast period owing to the growing demand for high-quality consumables such as reagents, kits, and disposable caps for sample collection, which are essential for maximizing the efficiency and accuracy of laser capture microdissection procedures.
By system type, the ultraviolet (UV) LCM segment accounted for the highest revenue-grossing segment in the global laser capture microdissection market in 2023 owing to the increasing adoption of UV LCM technology due to its superior precision, versatility, and compatibility with downstream molecular analysis applications, such as genomics and proteomics. For instance, Danaher Corporation stated in January 2022 that it had successfully acquired Aldevron, a supplier of premium plasmid DNA, mRNA, and proteins for biopharmaceutical applications. Additionally, the infrared (IR) LCM segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising demand for non-destructive tissue microdissection, improved sample preservation, and enhanced compatibility with a wider range of tissue types and downstream molecular analysis techniques.
By application, the research and development (R&D) segment accounted for the highest revenue-grossing segment in the global laser capture microdissection market in 2023 owing to the growing investments in research and development activities aimed at expanding the applications of laser capture microdissection across various fields, including oncology, neuroscience, and regenerative medicine. For instance, in January 2022, Danaher Corporation announced that it had acquired Aldevron, a provider of premium proteins, mRNA, and plasmid DNA for biopharmaceutical applications, successfully. Additionally, the diagnostics segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing demand for precise and reliable diagnostic tools for disease detection and personalized medicine, driving the adoption of laser capture microdissection technology in clinical diagnostics.
By end-user, the academic and government research institutes segment accounted for the highest revenue-grossing segment in the global laser capture microdissection market in 2023 owing to the increasing funding for life sciences research and collaborations between academic institutions and government agencies, driving the adoption of laser capture microdissection technology for various research applications. For instance, Crown Bioscience International (US), a JSR Life Sciences Company, purchased a 100% interest in Indivumed Services GmbH& Co. KG (Germany) in March 2023 in order to enhance drug discovery and develop solutions to satisfy client demands by integrating a range of complementary service platforms with Crown Bioscience's drug discovery and development offerings. Additionally, the pharmaceutical and biotechnology company segment is predicted to grow at the fastest CAGR during the forecast period owing to the growing focus on drug discovery, personalized medicine, and biomarker research, leading to increased investment in advanced technologies like laser capture microdissection for target identification and validation.
North American region is anticipated to have the highest revenue share during the forecast period owing to the region's well-established healthcare infrastructure, robust research and development activities, high adoption of advanced technologies, and presence of key market players driving innovation and market growth in laser capture microdissection. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the region's increasing investments in healthcare infrastructure, rising prevalence of chronic diseases, growing research and development activities, and expanding adoption of advanced biotechnological tools, including laser capture microdissection, across academic, clinical, and industrial sectors. For instance, Maastricht University published a research article in 2022 titled "Single-Cell RNA Sequencing and Laser Capture Microdissection-Based mRNA Expression Microarrays in Atherosclerosis Research."
This extensive research report concentrates on the size and projections of the global and regional markets from 2023 to 2034.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
- Study Coverage
- Market Forecast by Product, System Type, Application, and End-User
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of the Top 10+ Major Market Players
- 20% Free Customization Available to Meet Your Exact Requirement
Segmentation: Laser Capture Microdissection Market Report 2023 - 2034
Laser Capture Microdissection Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Mn)
- Instruments
- Consumables
- Software and Services
Laser Capture Microdissection Market Analysis & Forecast by System Type 2023 - 2034 (Revenue USD Mn)
- Ultraviolet LCM
- Infrared LCM
- Other System Types
Laser Capture Microdissection Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Mn)
- Research and Development
- Diagnostics
- Other Applications
Laser Capture Microdissection Market Analysis & Forecast by End-User 2023 - 2034 (Revenue USD Mn)
- Academic and Government Research Institutes
- Hospitals
- Pharmaceutical and Biotechnology Companies
- CROs
Laser Capture Microdissection Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Mn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Laser Capture Microdissection Market: Product Estimates & Trend Analysis
8. Laser Capture Microdissection Market: System Type Estimates & Trend Analysis
9. Laser Capture Microdissection Market: Application Estimates & Trend Analysis
10. Laser Capture Microdissection Market: End-user Estimates & Trend Analysis
11. Regional Market Analysis
12. North America Laser Capture Microdissection Market
13. Europe Global Laser Capture Microdissection Market
14. Asia Pacific Global Laser Capture Microdissection Market
15. Latin America Global Laser Capture Microdissection Market
16. MEA Global Laser Capture Microdissection Market
17. Competitor Analysis
18. Company Profiles
Companies Mentioned
- Leica Microsystems GmbH
- Thermo Fisher Scientific Inc.
- Molecular Machines & Industries GmbH (MMI)
- Carl Zeiss AG
- Danaher Corporation
- Indivumed GmbH
- Molecular Machines & Industries AG (MMI)
- 3DHISTECH Ltd.
- Applied Spectral Imaging Inc.
- Denator AB
- R&D Systems Inc.
- Avant Diagnostics Inc.
- Ocimum Biosolutions Ltd.
- SLABX A/S
- Theranostics Health Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | October 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 163.1 Million |
| Forecasted Market Value ( USD | $ 495.5 Million |
| Compound Annual Growth Rate | 10.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
